Dr. Rebecca Gladdy, from the University of Toronto, is giving a seminar at the RI-MUHC, on January 16, 2024, entitled "Smooth Muscle Tumors: Developmental Origins and Leveraging DNA Repair Deficiency" …ma-website.s3.us-east-2.amazonaws.com/2024/01/R-Glad…

Combination drug therapy shows promise for a treatment-resistant cancer medicalxpress.com/news/2024-01-c… via Medical Xpress

Proteins Suggest a Path to Reduce Drug Resistance in a Form of Cancer pnnl.gov/news-media/pro…

great collaboration between my lab and Sage Bionetworks Jineta Banerjee Angela Hirbe lab. Johns Hopkins NF1 Biospecimen repository samples - WES and RNAseq. Available now on NF data portal. NF Open Science Initiative Johns Hopkins Kimmel Cancer Center

Looking forward to #FrancisSCollinsScholar Dr. Chelsea Kotch’s talk on risk stratification for #NF1 associated tumors at the Pediatric Precision Medicine Cancer Care Summit hosted by UCSF next week! More info here: virtualce.ucsf.edu/Pediatric-Prec… #NF Johns Hopkins Medicine @NTAPresearch

In ASCO’s Daily News our NCI CCR Pediatric Oncology Branch-Test Account -Mayo Clinic #collaboration discuss the transformative potential for #cfDNA #liquidbx in hereditary cancer syndrome surveillance. We highlight strives by Dan Landau, Pugh Lab and others towards this 🥅 dailynews.ascopubs.org/do/understandi…

Shout out to co-authors Angela Hirbe Jack Shern Aadel Chaudhuri, MD PhD as well as twitterless Jeff Szymanski & Paul Jones. And thank you to Neurofibromatosis Therapeutic Acceleration Program & Children's Tumor Fdn for supporting our work towards this goal in the cancer predisposition #NF1! #childhoodcancer #cancerprevention

It was a blast writing a chapter on updated approaches to #MPNST #sarcoma with Carina Dehner, MD PhD, Dombi, Eulo, Gross, Lazar and lead Angela Hirbe for the ASCO education book. Check it out doi.org/10.1200/EDBK_4… and don’t miss the paired #ASCO2024 panel 5/31 4:30p S102! #ENDNF

Saying goodbye to an amazing two years at Test Account 🥂Feeling incredibly fortunate to have Angela Hirbe as a mentor on this journey! ❤️

Powerhouse panel! SARC hosting a review of SARC028 data on #ICI in #sarcoma - followed by a cage fight / debate on TLS as a biomarker! Moderated by the unmatched Sandra P D'Angelo, MD

Really impressive session for #mpnst #asco24 - so much work done but still need new therapies great summary by ⁦Angela Hirbe⁩

Pre/postop pembro + preop RT ➡️📈DFS vs. preop RT alone (70 v. 53%) for select G2/G3 resectable, extremity sarcomas (UPS + LPS), benefit namely in G3: tiny.cc/SARC032 David Kirsch, MD, PhD Richard Riedel Brian Van Tine SARC Dana-Farber News Dana-Farber Vinayak Venkataraman, MD#ASCO24

Angela Hirbe WashUOncology @WUSTLdbbs WUSM Department of Medicine

Exciting talk by Sara Gosline Gosline from PNNL on using model systems data to enable AI assisted drug response predictions … Children's Tumor Fdn #EndNF #NFcon24 Also.. cool enough to wear a party hat to celebrate a friends birthday 🥳 well done Dr Gosline !

NCI CCR Pediatric Oncology Branch’s all-star post-bac Omar Roman presents ground breaking work on the effect of selumetinib holds/interruptions on PN growth. Poster competition winter ➡️ platform talk with practice changing potential! Children's Tumor Fdn #CTF2024 #endNF

Lucky to have amazing colleagues and collaborators like NCI Center for Cancer Research-NCI Center for Cancer Research’s Dr. Xiyuan Zhang who presented amazing work using scRNAseq data to inform and improve clinical care! Children's Tumor Fdn #CTF2024 #endNF

A delightful time catching up with 10 of NTAP’s 18 Francis S. Collins Scholars & their mentors while in Brussels Children's Tumor Fdn. Thank you all for your dedication to moving the needle in NF1 research! #NFCON24 #endNF

So proud to present our poster at #CTF24. I’ve met incredible people, so happy to be in this #NF community! Special thanks to my mentor Angela Hirbe, sweetest person alive! #endnf #makenfvisible Children's Tumor Fdn

It was a huge privilege to co-lead the #liquidbx team with Pugh Lab. There are immense scientific + clinical opportunities w/ motivated multi-disciplinary teams working on them. I have no doubt that huge strides will be made in #NF1 care through #collaboration & #openscience!

So thankful for Children's Tumor Fdn’s incredible support that made our most recent publication possible (shorturl.at/amWS2; #tweetorial x.com/rtsundby/statu…). With Children's Tumor Fdn we are now working towards moving our findings from research to the clinic, stay tuned! #endNF